ACRS
Aclaris Therapeutics, Inc. · Healthcare
CFO Frank Ruffo sold $199K of Aclaris Therapeutics, Inc.
Sold$199,335
$15.55Price
12,823Shares
−6%Stake
What ACRS did after the filing
- The stock from Mon, Mar 14 close, $14.40
- −2.3%
- S&P 500, same days
- +0.1%
Measured over 30 trading days, to the Apr 26 close.
Traded Thu, Mar 10. Filed Mon, Mar 14, 12:56 PM ET, during the session. Returns use the Mar 14 close and the Apr 26 close. Not investment advice.